« Back
Home /
CeMMEC1

CeMMEC1

Item no.	DCC-DC9923-250mg
Manufacturer	DCChemicals
CASRN	440662-09-9
Amount	250 mg
Quantity options	100 mg 10 mM x 1 mL in DMSO 1 g 250 mg
Category	Oncology By Cell Type Blastoma Carcinoma Hematology Leukemia Lymphoma Myeloma Melanoma Sarcoma Reagents & Chemicals Molecules
Type	Inhibitors
Specific against	other
Purity	>98%
Smiles	O1CCOC2C=CC(=CC1=2)NC(C1=CN(C)C(C2C=CC=CC1=2)=O)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	440662-09-9
Similar products	440662-09-9
Available
Manufacturer - Applications	CeMMEC1 is a novel potent inhibitor of the second bromodomain of TAF1, binding neither the first nor the second bromodomain of BRD4.
Storage Conditions	4 Degree for 1 year, -20 degree for more than 2 years
Molecular Weight	336, 35
Note	For research only, not for human use.
Chemical name	N-(2, 3-Dihydrobenzo[b][1, 4]dioxin-6-yl)-2-methyl-1-oxo-1, 2-dihydroisoquinoline-4-carboxamide

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 250 mg

available

Delivery expected until 8/14/2025

Compare

Add to wishlist

Get an offer

Request delivery time